4 Stocks Pushing The Health Services Industry Higher
TheStreet Ratings group would like to highlight 4 stocks pushing the health services industry higher today, Nov. 15, 2012.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our modelAll three major indices are trading down today with the Dow Jones Industrial Average (^DJI) trading down 46 points (-0.4%) at 12,524 as of Thursday, Nov. 15, 2012, 12:05 PM ET. The NYSE advances/declines ratio sits at 797 issues advancing vs. 2,184 declining with 91 unchanged.The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.4%. Top gainers within the industry include Cigna (CI), up 1.8%, and Express Scripts (ESRX), up 0.7%. On the negative front, top decliners within the industry include Mindray Medical International (MR), down 2.2%, Cooper Companies (COO), down 1.3%, HCA Holdings (HCA), down 1.0% and Thermo Fisher Scientific (TMO), down 0.8%.TheStreet Ratings group would like to highlight 4 stocks pushing the industry higher today:4. Health Net (HNT) is one of the companies pushing the Health Services industry higher today. As of noon trading, Health Net is up $0.73 (3.1%) to $24.58 on average volume Thus far, 391,752 shares of Health Net exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $23.80-$24.63 after having opened the day at $23.80 as compared to the previous trading day's close of $23.85. Health Net, Inc., through its subsidiaries, provides managed health care services. Health Net has a market cap of $2.0 billion and is part of the health care sector. The company has a P/E ratio of 30.6, above the S&P 500 P/E ratio of 17.7. Shares are down 18.4% year to date as of the close of trading on Wednesday. Currently there are no analysts that rate Health Net a buy, 3 analysts rate it a sell, and 11 rate it a hold.TheStreet Ratings rates Health Net as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and disappointing return on equity. Get the full Health Net Ratings Report now.Latest Headlines about HNT
-
Health Insurers Gain On Medicare Advantage
09:40AM 04/03/13
-
Analysts' Actions: FRAN HNT IACI RY TD
08:51AM 12/04/12
-
5 Names Seeing Bullish Flow
11:30AM 11/15/12
-
Health Net's CEO Discusses Q2 2012 Results - Earnings Call Transcript
04:47PM 08/03/12
-
How Health Care Stocks Are Faring
09:46AM 06/28/12
-
Health Net's CEO Hosts Annual Shareholder Meeting (Transcript)
03:52PM 05/22/12
-
Analysts' Actions: CVC, HNT, WFM
09:02AM 05/04/12
Latest from TheStreet Wire
-
Dow Today: Home Depot (HD) Leads The Day Higher, International Business Machines (IBM) Lags
05:06PM 05/22/13
-
Adobe Systems Inc (ADBE): Today's Featured Computer Software & Services Laggard
05:01PM 05/22/13
-
Textron Inc (TXT): Today's Featured Aerospace/Defense Laggard
05:01PM 05/22/13
-
Health Care REIT Inc. (HCN): Today's Featured Real Estate Laggard
05:01PM 05/22/13
-
Emerson Electric Co. (EMR): Today's Featured Industrial Laggard
05:01PM 05/22/13
-
First Solar Inc. (FSLR): Today's Featured Electronics Laggard
05:01PM 05/22/13
-
Petroleo Brasileiro SA Petrobras (PBR): Today's Featured Basic Materials Laggard
05:01PM 05/22/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
